• Belgian scientists identify ATP10B as novel risk gene for Parkinson’s disease

    Friday April 10th 2020

  • Fujirebio Europe N.V. launches iAMP® COVID-19, a new molecular detection assay that eliminates the need for RNA extraction

    Thursday April 9th 2020

  • Biogazelle initiates large-scale testing of COVID-19 in Belgium

    Thursday April 2nd 2020

  • iTeos Therapeutics closes $125 million series B2 financing

    Thursday April 2nd 2020

  • Mithra announces Donesta® phase III clinical program update

    Thursday April 2nd 2020

  • Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

    Tuesday March 31st 2020

  • Belgische biotech sector blijft draaien ondanks de coronacrisis

    Friday March 27th 2020

  • Biocartis kondigt co-commercialisatie aan van de SeptiCyte® RAPID Test op Idylla™ (CE-IVD) en brengt update over COVID-19 impact

    Friday March 27th 2020

  • Your news here?

  • miDiagnostics raises €14m to accelerate the commercialization of its disruptive, lab-quality silicon chip diagnostics platform

    Thursday March 26th 2020

  • University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    Wednesday March 25th 2020

  • iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

    Wednesday February 26th 2020


Strategic Partners